𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tazarotene scales ahead in the psoriasis cost-effectiveness stakes

✍ Scribed by Todd, Carlene

Book ID
125333807
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
1998
Weight
221 KB
Volume
160
Category
Article
ISSN
1173-5503

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost of psoriasis: A study on the morbid
Cost of psoriasis: A study on the morbidity and financial effects of having psoriasis in Australia
✍ Nicole Jenner; Jan Campbell; Anne Plunkett; Robin Marks πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

## SUMMARY Eighty‐three participants with psoriasis were followed over a 2‐year period assessing the severity, morbidity and cost of their disease over time. At recruitment, they were examined by a dermatologist who classified them on a global basis as mild (47%), moderate (35%) or severe (18%). A